The group’s principal activities include developing and commercializing drug, cosmetic and nutritional products. The group products include Nurigene(TM) and Neotine(R). The group marketed its products uder the trade names Nurigene(TM) and Neotine(R). The group operates from the United States. The group’s revenue in the year 2005 was $477,199.
